Skip to main content
. 2017 Feb 10;13(3):195–199. doi: 10.11138/ccmbm/2016.13.3.195

Table 2.

Adverse drug reactions in patients treated with denosumab and alendronate.

Adverse drug reaction Denosumab Group
n (%)
Alendronate Group
n (%)
Hypocalcemia 3 (9.7) 0
Eczema 1 (3.2) 2 (6.4)
Urticaria 1 (3.2) 4 (12.9)
Rash 2 (6.4) 3 (9.7)
Abdominal discomfort 3 (9.7) 1 (3.2)
Nausea 1 (3.2) 1 (3.2)
Decreased appetite 3 (9.7) 1 (3.2)
Headache 1 (3.2) 4 (12.9)